Quantum BioPharma announced a 1,000,000 USD investment in Bitcoin, causing its Nasdaq shares to drop nearly 10%. This reflects the company’s effort to navigate market volatility through cryptocurrency.
In response to a 2.7% year-over-year increase in US CPI, firms like Jiva Technologies are also exploring Bitcoin for asset diversification. This trend indicates a shift in corporate financing strategies amidst inflation concerns.
Pressure mounts on giants like Amazon and Microsoft to adopt Bitcoin in treasury policies. Recent shareholder actions, including proposals to reconsider these strategies, indicate growing corporate interest in cryptocurrency.